| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/31/2013 | US20130029425 Genetic Inhibition by Double-Stranded RNA |
| 01/31/2013 | US20130029424 Method for the generation of monoclonal antibodies derived from human b cells |
| 01/31/2013 | US20130029423 Method of efficiently establishing induced pluripotent stem cells |
| 01/31/2013 | US20130029400 Genetic elements, proteins, and associated methods including application of addiitnal genetic information to gram (+) thermoacidophiles |
| 01/31/2013 | US20130029393 Recombinant ethanologenic bacteria |
| 01/31/2013 | US20130029386 Compositions and methods for the production of l-homoalanine |
| 01/31/2013 | US20130029384 Thermostable sucrose phosphorylase |
| 01/31/2013 | US20130029379 Virus-based vector compositions useful for transducing eukaryotic cells |
| 01/31/2013 | US20130029378 Novel enzyme |
| 01/31/2013 | US20130029359 Monoclonal antibodies and diagnostic uses thereof |
| 01/31/2013 | US20130029346 Vector and screening assay for cd44 expressing carcinomas |
| 01/31/2013 | US20130029342 Glycine riboswitches, methods for their use, and compositions for use with glycine riboswitches |
| 01/31/2013 | US20130029335 Spinocerebellar ataxia type 8 and methods of detection |
| 01/31/2013 | US20130029330 Mutant ldl receptor gene |
| 01/31/2013 | US20130029327 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof |
| 01/31/2013 | US20130028965 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 01/31/2013 | US20130028964 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION |
| 01/31/2013 | US20130028939 Chimeric human beta defensins |
| 01/31/2013 | US20130028931 Novel prrs virus inducing type i interferon in susceptible cells |
| 01/31/2013 | US20130028930 Albumin Derivatives and Variants |
| 01/31/2013 | US20130028926 Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells |
| 01/31/2013 | US20130028924 Constructs for enhancing immune responses |
| 01/31/2013 | US20130028923 Kdr peptides and vaccines comprising the same |
| 01/31/2013 | US20130028913 Antibody that binds to h-1 parvovirus |
| 01/31/2013 | US20130028908 MONOCLONAL ANTIBODIES DIRECTED AGAINST HIV p17 PROTEIN |
| 01/31/2013 | US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 01/31/2013 | US20130028894 Methods of treating il-tif associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors |
| 01/31/2013 | US20130028881 Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies |
| 01/31/2013 | US20130028876 Thymidine kinase |
| 01/31/2013 | US20130028868 Clinical applications of a recombinant human endostatin adenovirus (e10a) injection |
| 01/31/2013 | US20130028835 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 01/31/2013 | DE102011007991A1 Fermentatively producing D-phenylglycine comprises converting phenylpyruvate, phenylacetyl-coenzyme-A (coA), benzoylformyl-coA and benzoyl formate to phenylacetyl-coA, benzoylformyl-coA, benzoyl formate and D-phenylglycine, respectively |
| 01/31/2013 | CA2844357A1 Axmi270 toxin gene and methods for its use |
| 01/31/2013 | CA2843234A1 Method for screening induced pluripotent stem cells |
| 01/31/2013 | CA2843175A1 Insect resistant and herbicide tolerant soybean event 9582.814.19.1 |
| 01/31/2013 | CA2843172A1 Soybean event pdab9582.814.19.1 detection method |
| 01/31/2013 | CA2843168A1 Insect resistant and herbicide tolerant breeding stack of soybean event pdab9582.814.19.1 and pdab4468.04.16.1 |
| 01/31/2013 | CA2843042A1 Baculovirus system for the expression of a gene therapy vector |
| 01/31/2013 | CA2842835A1 Production of dha and other lc-pufas in plants |
| 01/31/2013 | CA2842833A1 Glyphosate tolerant corn event vco-o1981-5 and kit and method for detecting the same |
| 01/31/2013 | CA2842798A1 Recombinant virus products and methods for inhibition of expression of dux4 |
| 01/31/2013 | CA2842720A1 Methods and devices for electrical sample preparation |
| 01/31/2013 | CA2842642A1 Novel gene inducing elongation of roots or increasing biomass, and use therefor |
| 01/31/2013 | CA2842580A1 Technique for cleaving out part of poly(a) chain and/or 3'-terminal sequence of mrna to inhibit translation reaction |
| 01/31/2013 | CA2842530A1 Axmi205 variant proteins and methods for their use |
| 01/31/2013 | CA2842392A1 Improved baculovirus expression systems |
| 01/31/2013 | CA2841541A1 Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene |
| 01/31/2013 | CA2841461A1 Fermentation of glycerol to organic acids |
| 01/31/2013 | CA2840550A1 Plant transformation method |
| 01/31/2013 | CA2839964A1 Dna polymerases with improved activity |
| 01/31/2013 | CA2836992A1 Brassica plants yielding oils with a low alpha linolenic acid content |
| 01/30/2013 | EP2551356A1 Method for detecting target base sequence using competitive primer |
| 01/30/2013 | EP2551349A1 Genetically modified microorganism and production method for aliphatic polyester using same |
| 01/30/2013 | EP2551348A2 Production of galactosylated N-glycans in plants |
| 01/30/2013 | EP2551347A1 Pharmaceutical composition for preventing or treating cancer |
| 01/30/2013 | EP2551346A1 Aptamer for ngf and use thereof |
| 01/30/2013 | EP2551345A1 Hcv variant with high productivity of infectious hepatitis c virus, and use thereof |
| 01/30/2013 | EP2551343A1 Method for monitoring state of differentiation in stem cell |
| 01/30/2013 | EP2551280A2 Contraceptive peptides derived from spider venom |
| 01/30/2013 | EP2551256A1 Method for producing succinic acid |
| 01/30/2013 | EP2550976A2 Modulator compounds of the drug resistance in epithelial tumour cells |
| 01/30/2013 | EP2550974A2 Universal influenza vaccine based on recombinant modified vaccinia Ankara virus (MVA) |
| 01/30/2013 | EP2550363A1 Adam6 mice |
| 01/30/2013 | EP2550362A2 Cmv glycoproteins and recombinant vectors |
| 01/30/2013 | EP2550361A1 Compositions and methods for treating neurological disorders |
| 01/30/2013 | EP2550360A1 Bivalent antisense oligonucleotides |
| 01/30/2013 | EP2550359A1 Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof |
| 01/30/2013 | EP2550358A1 Modifying enzyme activity in plants |
| 01/30/2013 | EP2550356A2 Method of altering the differentiative state of a cell and compositions thereof |
| 01/30/2013 | EP2550298A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| 01/30/2013 | EP2550294A2 Prophylaxis of colorectal and gastrointestinal cancer |
| 01/30/2013 | EP2550292A2 Flavivirus host range mutations and uses thereof |
| 01/30/2013 | EP2550021A2 Methods of increasing efficiency of vector penetration of target tissue |
| 01/30/2013 | EP2550019A2 Temperature sensitive conjugate compositions, and uses related thereto |
| 01/30/2013 | EP2550013A1 Treating allergy with detoxified e. coli heat-labile enterotoxin |
| 01/30/2013 | EP2550010A1 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 01/30/2013 | EP2550000A1 Reduced size self-delivering rnai compounds |
| 01/30/2013 | CN1980947B Improved modulators of coagulation factors |
| 01/30/2013 | CN102906278A Assay for jc virus antibodies |
| 01/30/2013 | CN102906277A Single nucleotide polymorphism for prognosis of hepatocellular carcinoma |
| 01/30/2013 | CN102906276A Single nucleotide polymorphism for diagnosis of recurrence of hepatocellular carcinoma |
| 01/30/2013 | CN102906272A Microorganism producing o-phosphoserine and method of producing l-cysteine or derivatives thereof from o-phosphoserine using the same |
| 01/30/2013 | CN102906270A Recombinant thraustochytrids that grow on xylose, and compositions, methods of making, and uses thereof |
| 01/30/2013 | CN102906268A Compositions and methods for the increased production of isoprene and other products with 6 - phosphogluconolactonase (PGL) |
| 01/30/2013 | CN102906267A Identification of diurnal rhythms in photosynthetic and non-photosynthetic tissues from zea mays and use in improving crop plants |
| 01/30/2013 | CN102906266A Universal dengue virus sequences and methods of use |
| 01/30/2013 | CN102906265A Lipid binding nucleic acids |
| 01/30/2013 | CN102906264A Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8 |
| 01/30/2013 | CN102906263A Compositions for controlling varroa mites in bees |
| 01/30/2013 | CN102906262A Procedure for the specific isolation of total DNA content of bacterial germs and a kit for this purpose |
| 01/30/2013 | CN102906261A 突变型还原酶 Mutant reductase |
| 01/30/2013 | CN102906260A Plasmid vector |
| 01/30/2013 | CN102906259A Polynucleotide encoding acyl-coa synthetase homolog and method for using the same |
| 01/30/2013 | CN102906258A Ketoreductase mutant |
| 01/30/2013 | CN102906257A Modified family 5 cellulases and uses thereof |
| 01/30/2013 | CN102906255A Thermostable phytase variants |
| 01/30/2013 | CN102906254A Thermostable phytase variants |
| 01/30/2013 | CN102906253A Polypeptide having diterpene synthase activity |
| 01/30/2013 | CN102906252A Plants tolerant to HPPD inhibitor herbicides |
| 01/30/2013 | CN102906249A Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same |